FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
Read more at The New York Times
Topics
-
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.CNBC - 1h -
FDA OK's painkiller designed to end opioids' addiction and overdose risk
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.CBS News - 2h -
Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.MarketWatch - 5h -
FDA approves new type of non-opioid pain medication
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...The Hill - 12h -
US regulators approve new non-opioid drug to treat acute pain
Oral drug from Vertex, branded as Journavx, represents alternative to addictive opioids that have fueled US crisis . The US Food and Drug Administration approved a new drug to treat acute pain, the ...The Guardian - 14h -
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex Pharmaceuticals said.NBC News - 15h -
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.CNBC - 2d -
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.The Hill - Jan. 22
More from The New York Times
-
R.F.K. Jr., in His Own Words: Flu, Diabetes, Autism and More
Robert F. Kennedy Jr., President Trump’s nominee for health secretary, doesn’t just hold fringe views on vaccines. We fact-checked five recent statements.The New York Times - 15h -
N.I.H. Trials and Essential Hiring May Continue, Acting Director Says
The interim leader of the National Institutes of Health gave some clarification tied to Trump administrations restrictions on travel and communications, but questions remain.The New York Times - 1d -
Is the HPV Vaccine Safe? Yes, Despite What R.F.K. Jr. Has Said.
During his second day of confirmation hearings, Robert F. Kennedy Jr. declined to disavow comments he had made disparaging the vaccine as unsafe.The New York Times - 22h -
Fact-Checking RFK Jr.’s Health Claims on Obesity, Medicaid and Fluoride
Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made a number of disputed claims.The New York Times - 20h -
RFK Jr. Appears Unfamiliar With Key Elements of Medicare and Medicaid
In testimony to the Senate Finance Committee, Mr. Kennedy seemed to confuse the two government programs that cover more than 150 million Americans.The New York Times - 1d
More in Health
-
Mushers and dogs braved a horrific Alaska winter to deliver lifesaving serum 100 years ago
The Alaska Gold Rush town of Nome was hundreds of miles from anywhere, cut off by the frozen sea and under siege from a contagious disease known as the “strangling angel” for the way it suffocated ...ABC News - 8h -
R.F.K. Jr., in His Own Words: Flu, Diabetes, Autism and More
Robert F. Kennedy Jr., President Trump’s nominee for health secretary, doesn’t just hold fringe views on vaccines. We fact-checked five recent statements.The New York Times - 15h -
Long COVID Patients Frustrated That Federal Research Hasn't Found New Treatments
This is a MedPage Today story. Erica Hayes, 40, has not felt healthy since November 2020 when she first fell ill with COVID. Hayes is too sick to work, so she has spent much of the last 4 years ...ABC News - 18h -
Fact-Checking RFK Jr.’s Health Claims on Obesity, Medicaid and Fluoride
Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made a number of disputed claims.The New York Times - 20h -
What Is Spasmodic Dysphonia? RFK Jr.’s Condition Makes His Voice Raspy
Robert F. Kennedy Jr. started developing symptoms of the condition in 1996.The New York Times - 20h